Alterations in Cardiac Structure and Function in Hypertension

Hypertension and the Heart (SD Solomon and O Vardeny, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Hypertension and the Heart


Hypertension is a powerful risk factor for cardiovascular mortality and morbidity, including heart failure with both preserved and reduced ejection fraction. Hypertensive heart disease (HHD) defines the complex and diverse perturbations of cardiac structure and function occurring secondary to hypertension. Left ventricular hypertrophy (LVH) is one of the most recognized features of HHD and is an established risk factor for adverse cardiovascular (CV) outcomes in hypertension. Beyond LVH, LV geometry provides additional information regarding the cardiac response to hypertension. Imaging studies from larger cohorts of hypertensive patients reveal wide variability in the prevalence of LVH and LV geometric patterns, with the prevalence of concentric LVH similar to that of eccentric LVH. Hypertension is also associated with concomitant impairments in LV diastolic and systolic function. It remains uncertain why patients develop different patterns of LVH, although demographics and clinical comorbidities appear to influence that response.


Hypertension Ventricular remodeling Echocardiography 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513–8.PubMedGoogle Scholar
  2. 2.
    Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, et al. Predictors of new-onset heart failure: Differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6:279–86.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics–2013 update: A report from the american heart association. Circulation. 2013;127:e6–245.PubMedGoogle Scholar
  4. 4.
    Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.PubMedGoogle Scholar
  5. 5.
    Briasoulis A, Agarwal V, Tousoulis D, Stefanadis C. Effects of antihypertensive treatment in patients over 65 years of age: A meta-analysis of randomised controlled studies. Heart. 2014;100:317–23.Google Scholar
  6. 6.
    Georgiopoulou VV, Kalogeropoulos AP, Raggi P, Butler J. Prevention, diagnosis, and treatment of hypertensive heart disease. Cardiol Clin. 2010;28:675–91.PubMedGoogle Scholar
  7. 7.
    Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 esh/esc guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension (esh) and of the european society of cardiology (esc). Eur Heart J. 2013;34:2159–219.PubMedGoogle Scholar
  8. 8.
    Cacciapuoti F. Molecular mechanisms of left ventricular hypertrophy (lvh) in systemic hypertension (sh)-possible therapeutic perspectives. J Am Soc Hypertens. 2011;5:449–55.PubMedGoogle Scholar
  9. 9.
    Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al. The heart in hypertension. N Engl J Med. 1992;327:998–1008.PubMedGoogle Scholar
  10. 10.
    Gosse P, Cremer A, Vircoulon M, Coulon P, Jan E, Papaioannou G, et al. Prognostic value of the extent of left ventricular hypertrophy and its evolution in the hypertensive patient. J Hypertens. 2012;30:2403–9.PubMedGoogle Scholar
  11. 11.
    Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study. N Engl J Med. 1990;322:1561–6.PubMedGoogle Scholar
  12. 12.
    Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000;35:580–6.PubMedGoogle Scholar
  13. 13.
    Linzbach AJ. Heart failure from the point of view of quantitative anatomy. Am J Cardiol. 1960;5:370–82.PubMedGoogle Scholar
  14. 14.
    Devereux RB, Roman MJ. Left ventricular hypertrophy in hypertension: Stimuli, patterns, and consequences. Hypertens Res. 1999;22:1–9.PubMedGoogle Scholar
  15. 15.
    Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–52.PubMedGoogle Scholar
  16. 16.
    Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550–8.PubMedGoogle Scholar
  17. 17.
    Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56–64.PubMedCentralPubMedGoogle Scholar
  18. 18.
    Frey N, Olson EN. Cardiac hypertrophy: The good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45–79.PubMedGoogle Scholar
  19. 20.••
    Drazner MH. The progression of hypertensive heart disease. Circulation. 2011;123:327–34. A review of the major pathophysiologic mechanisms underlying hypertensive heart disease and an informative discussion of the diverse pathways that it can take in the progression to heart failure.PubMedGoogle Scholar
  20. 20.
    Iwashima Y, Horio T, Kamide K, Tokudome T, Yoshihara F, Nakamura S, et al. Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension. Am J Hypertens. 2010;23:290–8.PubMedGoogle Scholar
  21. 21.
    Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana G, et al. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: Data from the pamela population. Pressioni arteriose monitorate e loro associazioni. Hypertension. 2002;39:744–9.PubMedGoogle Scholar
  22. 22.
    Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Prevalence of left-ventricular hypertrophy in hypertension: An updated review of echocardiographic studies. J Hum Hypertens. 2012;26:343–9.PubMedGoogle Scholar
  23. 23.
    Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the american society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.PubMedGoogle Scholar
  24. 24.
    Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA. Lv mass assessed by echocardiography and cmr, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging. 2012;5:837–48.PubMedCentralPubMedGoogle Scholar
  25. 25.
    Ojji DB, Opie LH, Lecour S, Lacerda L, Adeyemi OM, Sliwa K. The effect of left ventricular remodelling on soluble st2 in a cohort of hypertensive subjects. J Hum Hypertens. 2014. doi:10.1038/jhh.2013.130.
  26. 26.
    Sinning C, Keller T, Zeller T, Ojeda F, Schluter M, Schnabel R, Lubos E, Bickel C, Lackner KJ, Diemert P, Munzel T, Blankenberg S, Wild PS. Association of high-sensitivity assayed troponin i with cardiovascular phenotypes in the general population: The population-based gutenberg health study. Clin Res Cardiol. 2014;103:211–22.Google Scholar
  27. 27.
    Rienstra M, Yin X, Larson MG, Fontes JD, Magnani JW, McManus DD, et al. Relation between soluble st2, growth differentiation factor-15, and high-sensitivity troponin i and incident atrial fibrillation. Am Heart J. 2014;167:109–115.e2.Google Scholar
  28. 28.
    de Simone G, Gottdiener JS, Chinali M, Maurer MS. Left ventricular mass predicts heart failure not related to previous myocardial infarction: The cardiovascular health study. Eur Heart J. 2008;29:741–7.PubMedGoogle Scholar
  29. 29.
    Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: The assessment of prognostic risk observational survey. J Hypertens. 2002;20:1307–14.PubMedGoogle Scholar
  30. 30.
    Andrikou E, Tsioufis C, Thomopoulos C, Andrikou I, Kasiakogias A, Leontsinis I, et al. Left ventricular mass index as a predictor of new-onset microalbuminuria in hypertensive subjects: A prospective study. Am J Hypertens. 2012;25:1195–201.PubMedGoogle Scholar
  31. 32.••
    Frohlich ED, Gonzalez A, Diez J. Hypertensive left ventricular hypertrophy risk: Beyond adaptive cardiomyocytic hypertrophy. J Hypertens. 2011;29:17–26. A comprehensive review of the pathophysiological mechanisms underlying hypertensive heart disease.PubMedGoogle Scholar
  32. 32.
    Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients. Am J Hypertens. 2005;18:23–9.PubMedGoogle Scholar
  33. 33.
    Conrady AO, Rudomanov OG, Zaharov DV, Krutikov AN, Vahrameeva NV, Yakovleva OI, et al. Prevalence and determinants of left ventricular hypertrophy and remodelling patterns in hypertensive patients: The st. Petersburg study. Blood Press. 2004;13:101–9.PubMedGoogle Scholar
  34. 34.
    Adebayo RA, Bamikole OJ, Balogun MO, Akintomide AO, Adeyeye VO, Bisiriyu LA, et al. Echocardiographic assessment of left ventricular geometric patterns in hypertensive patients in nigeria. Clin Med Insights Cardiol. 2013;7:161–7.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Devereux RB, de Simone G, Ganau A, Roman MJ. Left ventricular hypertrophy and geometric remodeling in hypertension: Stimuli, functional consequences and prognostic implications. J Hypertens Suppl. 1994;12:S117–27.PubMedGoogle Scholar
  36. 36.
    Fox ER, Taylor J, Taylor H, Han H, Samdarshi T, Arnett D, et al. Left ventricular geometric patterns in the jackson cohort of the atherosclerotic risk in communities (aric) study: Clinical correlates and influences on systolic and diastolic dysfunction. Am Heart J. 2007;153:238–44.PubMedGoogle Scholar
  37. 37.
    Akintunde A, Akinwusi O, Opadijo G. Left ventricular hypertrophy, geometric patterns and clinical correlates among treated hypertensive nigerians. Pan Afr Med J. 2010;4:8.PubMedGoogle Scholar
  38. 38.
    Gardin JM, McClelland R, Kitzman D, Lima JA, Bommer W, Klopfenstein HS, et al. M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the cardiovascular health study). Am J Cardiol. 2001;87:1051–7.PubMedGoogle Scholar
  39. 39.
    Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F, et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: The dallas heart study. Hypertension. 2005;46:124–9.PubMedGoogle Scholar
  40. 40.
    Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, et al. Differences in left ventricular structure between black and white hypertensive adults: The hypertension genetic epidemiology network study. Hypertension. 2004;43:1182–8.PubMedGoogle Scholar
  41. 41.
    Krumholz HM, Larson M, Levy D. Sex differences in cardiac adaptation to isolated systolic hypertension. Am J Cardiol. 1993;72:310–3.PubMedGoogle Scholar
  42. 42.
    Kuch B, Muscholl M, Luchner A, Doring A, Riegger GA, Schunkert H, et al. Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens. 1998;12:685–91.PubMedGoogle Scholar
  43. 43.
    Vasan RS, Evans JC, Benjamin EJ, Levy D, Larson MG, Sundstrom J, et al. Relations of serum aldosterone to cardiac structure: Gender-related differences in the framingham heart study. Hypertension. 2004;43:957–62.PubMedGoogle Scholar
  44. 44.
    Saba MM, Ibrahim MM, Rizk HH. Gender and the relationship between resting heart rate and left ventricular geometry. J Hypertens. 2001;19:367–73.PubMedGoogle Scholar
  45. 45.
    Muscholl MW, Schunkert H, Muders F, Elsner D, Kuch B, Hense HW, et al. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension. Am Heart J. 1998;135:58–66.PubMedGoogle Scholar
  46. 46.
    Teuscher A, Egger M, Herman JB. Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population. Arch Intern Med. 1989;149:1942–5.PubMedGoogle Scholar
  47. 47.
    Colosia AD, Palencia R, Khan S. Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: A systematic literature review. Diabetes Metab Syndr Obes. 2013;6:327–38.PubMedCentralPubMedGoogle Scholar
  48. 48.
    Palmieri V, Bella JN, Arnett DK, Liu JE, Oberman A, Schuck MY, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension genetic epidemiology network (hypergen) study. Circulation. 2001;103:102–7.PubMedGoogle Scholar
  49. 49.
    Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the framingham heart study). Am J Cardiol. 1991;68:85–9.PubMedGoogle Scholar
  50. 50.
    Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, et al. Impact of diabetes on cardiac structure and function: The strong heart study. Circulation. 2000;101:2271–6.PubMedGoogle Scholar
  51. 51.
    Buono F, Crispo S, Pagano G, Rengo G, Petitto M, Grieco F, et al. Determinants of left ventricular hypertrophy in patients with recent diagnosis of essential hypertension. J Hypertens. 2014;32:166–73.PubMedGoogle Scholar
  52. 52.
    Chrostowska M, Szyndler A, Hoffmann M, Narkiewicz K. Impact of obesity on cardiovascular health. Best Pract Res Clin Endocrinol Metab. 2013;27:147–56.PubMedGoogle Scholar
  53. 53.
    de Simone G. Morbid obesity and left ventricular geometry. Hypertension. 2007;49:7–9.PubMedGoogle Scholar
  54. 55.••
    Owan T, Avelar E, Morley K, Jiji R, Hall N, Krezowski J, et al. Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the utah obesity study. J Am Coll Cardiol. 2011;57:732–9. This study provides empiric evidence of the reversibility of cardiac changes associated with obesity.PubMedCentralPubMedGoogle Scholar
  55. 55.
    Luaces M, Cachofeiro V, Garcia-Munoz-Najar A, Medina M, Gonzalez N, Cancer E, et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev Esp Cardiol (Engl). 2012;65:14–21.Google Scholar
  56. 56.
    Cuspidi C, Rescaldani M, Sala C, Grassi G. Left-ventricular hypertrophy and obesity: A systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2014;32:16–25.PubMedGoogle Scholar
  57. 57.
    Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186–92.PubMedGoogle Scholar
  58. 58.
    Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: Effects on the cardiovascular system. Circulation. 2007;116:85–97.PubMedGoogle Scholar
  59. 59.
    Grabysa R, Wankowicz Z. Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease. Med Sci Monit. 2013;19:838–45.PubMedCentralPubMedGoogle Scholar
  60. 60.
    Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334–41.PubMedGoogle Scholar
  61. 61.
    Foley RN, Curtis BM, Randell EW, Parfrey PS. Left ventricular hypertrophy in new hemodialysis patients without symptomatic cardiac disease. Clin J Am Soc Nephrol. 2010;5:805–13.PubMedCentralPubMedGoogle Scholar
  62. 62.
    Hashimoto J, Westerhof BE, Westerhof N, Imai Y, O'Rourke MF. Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment. J Hypertens. 2008;26:1017–24.PubMedGoogle Scholar
  63. 63.
    Kobayashi S, Yano M, Kohno M, Obayashi M, Hisamatsu Y, Ryoke T, et al. Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. Circulation. 1996;94:3362–8.PubMedGoogle Scholar
  64. 64.
    Lai S, Coppola B, Dimko M, Galani A, Innico G, Frassetti N, et al. Vitamin d deficiency, insulin resistance, and ventricular hypertrophy in the early stages of chronic kidney disease. Ren Fail. 2014;36:58–64.PubMedGoogle Scholar
  65. 65.
    Martinez-Vea A, Marcas L, Bardaji A, Romeu M, Gutierrez C, Garcia C, et al. Role of oxidative stress in cardiovascular effects of anemia treatment with erythropoietin in predialysis patients with chronic kidney disease. Clin Nephrol. 2012;77:171–81.PubMedGoogle Scholar
  66. 66.
    Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 1995;25:871–8.PubMedGoogle Scholar
  67. 67.
    Pierdomenico SD, Lapenna D, Bucci A, Manente BM, Cuccurullo F, Mezzetti A. Prognostic value of left ventricular concentric remodeling in uncomplicated mild hypertension. Am J Hypertens. 2004;17:1035–9.PubMedGoogle Scholar
  68. 68.
    Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004;43:731–8.PubMedGoogle Scholar
  69. 69.•
    Apostolakis S, Sullivan RM, Olshansky B, Lip GY. Left ventricular geometry and outcomes in patients with atrial fibrillation: The affirm trial. Int J Cardiol. 2014;170:303–8. This study demonstrates that even in a population at high-risk for cardiovascular events, hypertension-associated changes in cardiac structure provides independent prognostic information.PubMedGoogle Scholar
  70. 70.
    Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, et al. Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy. Am J Cardiol. 1996;78:197–202.PubMedGoogle Scholar
  71. 71.
    Ghali JK, Liao Y, Cooper RS. Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease. J Am Coll Cardiol. 1998;31:1635–40.PubMedGoogle Scholar
  72. 72.
    Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the framingham heart study. J Am Coll Cardiol. 1995;25:879–84.PubMedGoogle Scholar
  73. 73.
    Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, et al. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Am J Cardiol. 2014;113:117–22.PubMedGoogle Scholar
  74. 74.••
    Gaasch WH, Zile MR. Left ventricular structural remodeling in health and disease: With special emphasis on volume, mass, and geometry. J Am Coll Cardiol. 2011;58:1733–40. A comprehensive review of the importance of considering geometric cardiac changes in a wide spectrum of cardiovascular diseases.PubMedGoogle Scholar
  75. 75.
    Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: The dallas heart study. Circ Cardiovasc Imaging. 2010;3:164–71.PubMedGoogle Scholar
  76. 76.•
    Bang CN, Gerdts E, Aurigemma GP, Boman K, Dahlof B, Roman MJ, et al. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: The losartan intervention for endpoint reduction in hypertension study. J Hypertens. 2013;31:2060–8. Echocardiographic substudy of a clinical trial demonstrating that including left ventricle volume in the classification of cardiac geometry can improve the detection of systolic dysfunction in hypertensive patients.PubMedGoogle Scholar
  77. 77.
    Bella JN, Palmieri V, Roman MJ, Liu JE, Welty TK, Lee ET, et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: The strong heart study. Circulation. 2002;105:1928–33.PubMedGoogle Scholar
  78. 78.
    Redfield MM, Jacobsen SJ, Burnett Jr JC, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202.PubMedGoogle Scholar
  79. 79.
    de Simone G, Kitzman DW, Chinali M, Oberman A, Hopkins PN, Rao DC, et al. Left ventricular concentric geometry is associated with impaired relaxation in hypertension: The hypergen study. Eur Heart J. 2005;26:1039–45.PubMedGoogle Scholar
  80. 80.
    ADVANCE Echocardiography Substudy Investigators, ADVANCE Collaborative Group.. Effects of perindopril-indapamide on left ventricular diastolic function and mass in patients with type 2 diabetes: The advance echocardiography substudy. J Hypertens. 2011;29:721 1439–1447.Google Scholar
  81. 81.
    Sharp AS, Tapp RJ, Thom SA, Francis DP, Hughes AD, Stanton AV, et al. Tissue doppler e/e' ratio is a powerful predictor of primary cardiac events in a hypertensive population: An ascot substudy. Eur Heart J. 2010;31:747–52.PubMedGoogle Scholar
  82. 82.
    Wachtell K, Smith G, Gerdts E, Dahlof B, Nieminen MS, Papademetriou V, et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the life study). Losartan intervention for endpoint. Am J Cardiol. 2000;85:466–72.PubMedGoogle Scholar
  83. 83.
    Pearson AC, Labovitz AJ, Mrosek D, Williams GA, Kennedy HL. Assessment of diastolic function in normal and hypertrophied hearts: Comparison of doppler echocardiography and m-mode echocardiography. Am Heart J. 1987;113:1417–25.PubMedGoogle Scholar
  84. 84.
    Douglas PS, Berko B, Lesh M, Reichek N. Alterations in diastolic function in response to progressive left ventricular hypertrophy. J Am Coll Cardiol. 1989;13:461–7.PubMedGoogle Scholar
  85. 85.
    Chahal NS, Lim TK, Jain P, Chambers JC, Kooner JS, Senior R. New insights into the relationship of left ventricular geometry and left ventricular mass with cardiac function: A population study of hypertensive subjects. Eur Heart J. 2010;31:588–94.PubMedGoogle Scholar
  86. 86.
    Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, et al. Left atrial size: Physiologic determinants and clinical applications. J Am Coll Cardiol. 2006;47:2357–63.PubMedGoogle Scholar
  87. 87.
    Tsioufis C, Stougiannos P, Taxiarchou E, Skiadas I, Chatzis D, Thomopoulos C, et al. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension. J Hypertens. 2006;24:965–72.PubMedGoogle Scholar
  88. 88.
    Cuspidi C, Rescaldani M, Sala C. Prevalence of echocardiographic left-atrial enlargement in hypertension: A systematic review of recent clinical studies. Am J Hypertens. 2013;26:456–64.PubMedGoogle Scholar
  89. 89.
    Kizer JR, Bella JN, Palmieri V, Liu JE, Best LG, Lee ET, et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: The strong heart study (shs). Am Heart J. 2006;151:412–8.PubMedGoogle Scholar
  90. 90.
    Verdecchia P, Angeli F, Gattobigio R, Sardone M, Porcellati C. Asymptomatic left ventricular systolic dysfunction in essential hypertension: Prevalence, determinants, and prognostic value. Hypertension. 2005;45:412–8.PubMedGoogle Scholar
  91. 91.
    The SOLVD investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The solvd investigattors. N Engl J Med. 1992;327:685–691.Google Scholar
  92. 92.
    Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195–202.PubMedGoogle Scholar
  93. 93.
    de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation. 1996;93:259–65.PubMedGoogle Scholar
  94. 94.
    Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: A speckle-strain imaging study. Circ Cardiovasc Imaging. 2009;2:382–90.PubMedGoogle Scholar
  95. 95.
    Kosmala W, Plaksej R, Strotmann JM, Weigel C, Herrmann S, Niemann M, et al. Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: An ultrasonic two-dimensional speckle tracking study. J Am Soc Echocardiogr. 2008;21:1309–17.PubMedGoogle Scholar
  96. 96.
    Leggio M, Sgorbini L, Pugliese M, Mazza A, Bendini MG, Fera MS, et al. Systo-diastolic ventricular function in patients with hypertension: An echocardiographic tissue doppler imaging evaluation study. Int J Cardiovasc Imaging. 2007;23:177–84.PubMedGoogle Scholar
  97. 97.
    Rosen BD, Edvardsen T, Lai S, Castillo E, Pan L, Jerosch-Herold M, et al. Left ventricular concentric remodeling is associated with decreased global and regional systolic function: The multi-ethnic study of atherosclerosis. Circulation. 2005;112:984–91.PubMedGoogle Scholar
  98. 98.
    de Simone G, Kitzman DW, Palmieri V, Liu JE, Oberman A, Hopkins PN, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: The hypergen study. Am J Hypertens. 2004;17:828–33.PubMedGoogle Scholar
  99. 100.•
    Cuspidi C, Sala C, Muiesan ML, De Luca N, Schillaci G. Right ventricular hypertrophy in systemic hypertension: An updated review of clinical studies. J Hypertens. 2013;31:858–65. A recent review that calls attention to the impact of hypertension on the right ventricle.PubMedGoogle Scholar
  100. 100.
    Cuspidi C, Negri F, Giudici V, Valerio C, Meani S, Sala C, et al. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension. J Hypertens. 2009;27:854–60.PubMedGoogle Scholar
  101. 101.
    Ivanovic BA, Tadic MV, Celic VP. To dip or not to dip? The unique relationship between different blood pressure patterns and cardiac function and structure. J Hum Hypertens. 2013;27:62–70.PubMedGoogle Scholar
  102. 102.
    Lourenco AP, Roncon-Albuquerque Jr R, Bras-Silva C, Faria B, Wieland J, Henriques-Coelho T, et al. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol. 2006;291:H1587–94.PubMedGoogle Scholar
  103. 103.
    Laks MM, Morady F. Norepinephrine–the myocardial hypertrophy hormone? Am Heart J. 1976;91:674–5.PubMedGoogle Scholar
  104. 104.
    Tadic M, Cuspidi C, Suzic-Lazic J, Andric A, Stojcevski B, Ivanovic B, Hot S, Scepanovic R, Celic V. Is there a relationship between right-ventricular and right atrial mechanics and functional capacity in hypertensive patients? J Hypertens. 2014Google Scholar
  105. 106.••
    Barron AJ, Hughes AD, Sharp A, Baksi AJ, Surendran P, Jabbour RJ, et al. Long-term antihypertensive treatment fails to improve e/e' despite regression of left ventricular mass: An anglo-scandinavian cardiac outcomes trial substudy. Hypertension. 2014;63:252–8. An echocardiographic substudy of a hypertension therapeutic trial demonstrating a divergent effect of antihypertensive treatment on left ventricle hypertrophy and diastolic function.PubMedGoogle Scholar
  106. 106.
    Fagard RH, Celis H, Thijs L, Wouters S. Regression of left ventricular mass by antihypertensive treatment: A meta-analysis of randomized comparative studies. Hypertension. 2009;54:1084–91.PubMedGoogle Scholar
  107. 107.
    Wachtell K, Dahlof B, Rokkedal J, Papademetriou V, Nieminen MS, Smith G, et al. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: The losartan intervention for endpoint reduction in hypertension (life) study. Am Heart J. 2002;144:1057–64.PubMedGoogle Scholar
  108. 108.
    Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: A randomised trial. Lancet. 2007;369:2079–87.PubMedGoogle Scholar
  109. 109.
    Solomon SD, Verma A, Desai A, Hassanein A, Izzo J, Oparil S, et al. Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction. Hypertension. 2010;55:241–8.PubMedGoogle Scholar
  110. 110.
    Almuntaser I, Mahmud A, Brown A, Murphy R, King G, Crean P, et al. Blood pressure control determines improvement in diastolic dysfunction in early hypertension. Am J Hypertens. 2009;22:1227–31.PubMedGoogle Scholar
  111. 111.
    Diez J, Frohlich ED. A translational approach to hypertensive heart disease. Hypertension. 2010;55:1–8.PubMedGoogle Scholar
  112. 112.
    Burchfield JS, Xie M, Hill JA. Pathological ventricular remodeling: Mechanisms: Part 1 of 2. Circulation. 2013;128:388–400.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Physiology and Cardiothoracic Surgery, Cardiovascular R&D Unit, Faculty of MedicineUniversity of PortoPortoPortugal
  2. 2.Division of Cardiovascular MedicineBrigham and Women’s HospitalBostonUSA

Personalised recommendations